Jd Health International Inc vs Apotea AB (publ): Fair Value & Quality
Both stocks run through our valuation models. Here is how Jd Health International Inc (6618) and Apotea AB (publ) (APOTEA) compare, as of Sep 5, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Jd Health International Inc leads: 6 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Jd Health International IncPrice HK$37.06 | Apotea AB (publ)Price SEK 77.30 |
|---|---|---|
| DCF Models | ▲+90%above the priceHK$70.32 | ▼-18%below the priceSEK 63.71 |
| Earnings-Based | ▲+38%above the priceHK$51.28 | ●-1%close to the priceSEK 76.91 |
| Multiples | ▼-23%below the priceHK$28.65 | ▼-44%below the priceSEK 43.16 |
| Asset-Based | ▼-66%below the priceHK$12.62 | ▼-93%below the priceSEK 5.43 |
| Growth DCF | ▲+110%above the priceHK$77.68 | ▼-43%below the priceSEK 43.84 |
| Economic Profit | ▼-44%below the priceHK$20.89 | ▼-59%below the priceSEK 31.99 |
| Growth Earnings | ▲+89%above the priceHK$70.00 | ▲+32%above the priceSEK 102 |
| Minimum | ▼-66%below the priceHK$12.62 | ▼-93%below the priceSEK 5.43 |
| Maximum | ▲+110%above the priceHK$77.68 | ▲+32%above the priceSEK 102 |
| Median | ▲+38%above the priceHK$51.28 | ▼-43%below the priceSEK 43.84 |
| Geometric mean | ●+6%close to the priceHK$39.43 | ▼-48%below the priceSEK 40.02 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Jd Health International Inc: 9 of 24 models see the stock below the current price.
Apotea AB (publ): 21 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Jd Health International Inc · Health Care
Apotea AB (publ) · Health Care
Bottom line
As of Sep 5, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Jd Health International Inc trades at HK$37.06 versus a fair value of HK$33.31 (-10%), while Apotea AB (publ) trades at SEK 77.30 versus SEK 46.46 (-40%).
Jd Health International Inc has the higher quality score (72/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Jd Health International Inc
Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth GroupSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.